Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Avadel Pharmaceuticals EBITDA Margin 2011-2025 | AVDL

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Avadel Pharmaceuticals (AVDL) over the last 10 years. The current EBITDA margin for Avadel Pharmaceuticals as of June 30, 2025 is .
Avadel Pharmaceuticals EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-06-30 $0.22B $0.01B 2.71%
2025-03-31 $0.20B $-0.02B -8.21%
2024-12-31 $0.17B $-0.04B -23.08%
2024-09-30 $0.14B $-0.06B -44.20%
2024-06-30 $0.10B $-0.10B -102.11%
2024-03-31 $0.05B $-0.13B -248.15%
2020-06-30 $0.05B $0.02B 51.06%
2020-03-31 $0.06B $-0.02B -38.18%
2019-12-31 $0.06B $-0.02B -38.98%
2019-09-30 $0.07B $-0.09B -130.43%
2019-06-30 $0.08B $-0.10B -129.33%
2019-03-31 $0.09B $-0.09B -108.14%
2018-12-31 $0.10B $-0.10B -92.23%
2018-09-30 $0.12B $-0.02B -18.80%
2018-06-30 $0.14B $0.02B 11.68%
2018-03-31 $0.15B $0.05B 33.12%
2017-12-31 $0.17B $0.10B 54.60%
2017-09-30 $0.18B $0.12B 63.74%
2017-06-30 $0.17B $0.08B 44.25%
2017-03-31 $0.17B $0.03B 20.36%
2016-12-31 $0.15B $0.01B 6.00%
2016-09-30 $0.15B $0.07B 46.00%
2016-06-30 $0.17B $0.07B 42.42%
2016-03-31 $0.18B $0.08B 45.14%
2015-12-31 $0.17B $0.08B 48.26%
2015-09-30 $0.13B $-0.06B -46.21%
2015-06-30 $0.09B $-0.05B -57.61%
2015-03-31 $0.05B $-0.06B -107.84%
2014-12-31 $0.03B $-0.07B -251.85%
2014-09-30 $0.03B $-0.03B -93.33%
2014-06-30 $0.03B $-0.03B -103.45%
2014-03-31 $0.03B $-0.03B -125.93%
2013-12-31 $0.02B $-0.04B -186.96%
2013-09-30 $0.02B $-0.02B -91.67%
2013-06-30 $0.02B $-0.02B -95.65%
2013-03-31 $0.02B $-0.02B -95.65%
2012-12-31 $0.03B $-0.02B -68.00%
2012-09-30 $0.03B $-0.02B -59.26%
2012-06-30 $0.03B $-0.01B -28.13%
2012-03-31 $0.03B $-0.01B -21.21%
2011-12-31 $0.03B $-0.01B -21.21%
2011-09-30 $0.04B $0.00B -5.41%
2011-06-30 $0.04B $-0.01B -17.14%
2011-03-31 $0.04B $-0.01B -19.44%
2010-12-31 $0.04B $-0.01B -16.22%
2010-09-30 $0.04B $-0.01B -22.86%
2010-06-30 $0.04B $-0.01B -27.03%
2010-03-31 $0.04B $-0.01B -25.64%
2009-12-31 $0.04B $-0.01B -13.95%
2009-09-30 $0.04B $-0.01B -24.39%
2009-06-30 $0.04B $-0.01B -22.50%
2009-03-31 $0.04B $-0.01B -23.08%
2008-12-31 $0.04B $-0.01B -34.21%
2008-09-30 $0.04B $-0.02B -40.00%
2008-06-30 $0.04B $-0.02B -52.50%
2008-03-31 $0.04B $-0.03B -76.32%
2007-12-31 $0.04B $-0.03B -91.89%
2007-09-30 $0.03B $-0.04B -102.94%
2007-06-30 $0.03B $-0.04B -120.00%
2007-03-31 $0.03B $-0.03B -114.29%
2006-12-31 $0.02B $-0.03B -143.48%
2006-09-30 $0.02B $-0.04B -171.43%
2006-06-30 $0.02B $-0.04B -200.00%
2006-03-31 $0.02B $-0.04B -190.00%
2005-12-31 $0.02B $-0.04B -156.52%
2005-09-30 $0.04B $-0.02B -55.56%
2005-06-30 $0.05B $-0.01B -13.04%
2005-03-31 $0.05B 0 0.00%
2004-12-31 $0.06B $0.01B 20.00%
2004-09-30 $0.05B $0.01B 14.89%
2004-06-30 $0.04B $0.00B 7.69%
2004-03-31 $0.04B $0.00B 8.57%
2003-12-31 $0.03B $0.00B -12.00%
2003-09-30 $0.02B $-0.01B -26.32%
2003-06-30 $0.02B $0.00B -10.00%
2003-03-31 $0.02B 0 0.00%
2002-12-31 $0.02B $0.00B 15.00%
2002-09-30 $0.02B $0.01B 40.00%
2002-06-30 $0.02B $0.01B 52.94%
2002-03-31 $0.02B $0.01B 73.33%
2001-12-31 $0.01B $0.01B 100.00%
2001-09-30 $0.01B $0.01B 100.00%
2001-06-30 $0.01B $0.01B 100.00%
2001-03-31 $0.01B $0.01B 100.00%
2000-12-31 $0.01B $0.01B 100.00%
2000-09-30 $0.02B $0.02B 100.00%
2000-06-30 $0.01B $0.01B 100.00%
2000-03-31 $0.01B $0.01B 100.00%
1999-12-31 $0.01B $0.01B 100.00%
1999-06-30 $0.01B $0.01B 100.00%
1999-03-31 $0.01B $0.01B 100.00%
1998-12-31 $0.01B $0.01B 100.00%
1998-09-30 $0.01B $0.01B 100.00%
1998-06-30 $0.01B $0.01B 100.00%
1998-03-31 $0.01B $0.01B 100.00%
1997-12-31 $0.01B $0.01B 100.00%
1997-09-30 $0.01B $0.01B 100.00%
1997-06-30 $0.01B $0.01B 100.00%
1997-03-31 $0.01B $0.01B 100.00%
1996-12-31 $0.01B $0.01B 100.00%
1996-09-30 $0.01B $0.01B 100.00%
1996-06-30 $0.00B $0.00B 100.00%
1996-03-31 $0.00B $0.00B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.815B $0.169B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.709B 30.27
Zoetis (ZTS) United States $52.989B 18.97
Takeda Pharmaceutical (TAK) Japan $43.466B 8.87
Daiichi Sankyo, - (DSNKY) Japan $41.562B 20.70
BeOne Medicines - (ONC) Switzerland $35.089B 186.03
Sandoz Group AG (SDZNY) Switzerland $29.014B 0.00
United Therapeutics (UTHR) United States $19.329B 17.01
Merck (MKKGY) Germany $16.401B 10.66
Neurocrine Biosciences (NBIX) United States $15.192B 36.45
Shionogi (SGIOY) Japan $14.411B 13.23
Summit Therapeutics (SMMT) United States $14.020B 0.00
Ionis Pharmaceuticals (IONS) United States $11.913B 0.00
IPSEN (IPSEY) France $11.841B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.112B 0.00
Orion OYJ (ORINY) Finland $8.719B 24.91
Eisai (ESAIY) $8.166B 0.00
Corcept Therapeutics (CORT) United States $7.754B 83.77
Stevanato Group S.p.A (STVN) Italy $7.299B 40.85
Grifols, S.A (GRFS) Spain $5.803B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.546B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.140B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.767B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.571B 16.97
Centessa Pharmaceuticals (CNTA) United Kingdom $2.962B 0.00
Hypermarcas (HYPMY) Brazil $2.958B 22.24
Catalyst Pharmaceuticals (CPRX) United States $2.629B 8.39
Dyne Therapeutics (DYN) United States $2.622B 0.00
Soleno Therapeutics (SLNO) United States $2.562B 0.00
Ocular Therapeutix (OCUL) United States $2.312B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.926B 22.83
Guardian Pharmacy Services (GRDN) United States $1.824B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.493B 88.62
Ardelyx (ARDX) United States $1.358B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.352B 0.00
Collegium Pharmaceutical (COLL) United States $1.337B 6.62
Harrow (HROW) United States $1.255B 0.00
Xeris Biopharma Holdings (XERS) United States $1.233B 0.00
Oruka Therapeutics (ORKA) United States $1.153B 0.00
Evotec AG (EVO) Germany $1.094B 0.00
Nektar Therapeutics (NKTR) United States $1.064B 0.00
Relay Therapeutics (RLAY) United States $1.049B 0.00
Enliven Therapeutics (ELVN) United States $1.044B 0.00
Xencor (XNCR) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.950B 0.00
ARS Pharmaceuticals (SPRY) United States $0.875B 0.00
ProKidney (PROK) United States $0.850B 0.00
Theravance Biopharma (TBPH) United States $0.743B 61.46
Aquestive Therapeutics (AQST) United States $0.737B 0.00
Organogenesis (ORGO) United States $0.714B 0.00
Savara (SVRA) United States $0.683B 0.00
Elite Pharmaceuticals (ELTP) United States $0.674B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.639B 5.70
Bioventus (BVS) United States $0.616B 12.63
KalVista Pharmaceuticals (KALV) United States $0.545B 0.00
Akebia Therapeutics (AKBA) United States $0.541B 0.00
Esperion Therapeutics (ESPR) United States $0.536B 0.00
Zevra Therapeutics (ZVRA) United States $0.496B 0.00
4D Molecular Therapeutics (FDMT) United States $0.490B 0.00
Siga Technologies (SIGA) United States $0.468B 6.41
Lexeo Therapeutics (LXEO) United States $0.442B 0.00
Altimmune (ALT) United States $0.429B 0.00
USANA Health Sciences (USNA) United States $0.350B 9.76
Lyell Immunopharma (LYEL) United States $0.336B 0.00
Galectin Therapeutics (GALT) United States $0.335B 0.00
Korro Bio (KRRO) United States $0.318B 0.00
Nature's Sunshine Products (NATR) United States $0.314B 18.67
Ironwood Pharmaceuticals (IRWD) United States $0.312B 48.00
Larimar Therapeutics (LRMR) United States $0.286B 0.00
Aldeyra Therapeutics (ALDX) United States $0.282B 0.00
Aclaris Therapeutics (ACRS) United States $0.251B 0.00
Achieve Life Sciences (ACHV) Canada $0.244B 0.00
Pyxis Oncology (PYXS) United States $0.243B 0.00
Journey Medical (DERM) United States $0.240B 0.00
AleAnna (ANNA) United States $0.212B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
OmniAb (OABI) United States $0.199B 0.00
Avalo Therapeutics (AVTX) United States $0.198B 0.00
MediWound (MDWD) Israel $0.195B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
Protara Therapeutics (TARA) United States $0.166B 0.00
China SXT Pharmaceuticals (SXTC) China $0.159B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.149B 0.00
Cassava Sciences (SAVA) United States $0.143B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
Incannex Healthcare (IXHL) Australia $0.121B 0.00
Inhibikase Therapeutics (IKT) United States $0.112B 0.00
Surrozen (SRZN) United States $0.105B 0.00
Context Therapeutics (CNTX) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Avita Medical (RCEL) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Champions Oncology (CSBR) United States $0.093B 33.70
Karyopharm Therapeutics (KPTI) United States $0.088B 0.00
Relmada Therapeutics (RLMD) United States $0.088B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.076B 0.00
Lite Strategy (LITS) United States $0.075B 0.00
Plus Therapeutics (PSTV) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.073B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.071B 0.00
Gain Therapeutics (GANX) United States $0.070B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Prelude Therapeutics (PRLD) United States $0.067B 0.00
Rafael Holdings (RFL) United States $0.067B 0.00
BioNxt Solutions (BNXTF) Canada $0.060B 0.00
Acrivon Therapeutics (ACRV) United States $0.059B 0.00
PolyPid (PYPD) Israel $0.058B 0.00
Talphera (TLPH) United States $0.058B 0.00
Wellgistics Health (WGRX) United States $0.057B 0.00
Fractyl Health (GUTS) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Inotiv (NOTV) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 26.62
Liminatus Pharma (LIMN) United States $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Mangoceuticals (MGRX) United States $0.023B 0.00
Cosmos Health (COSM) United States $0.021B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Vyome Holdings (HIND) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Heatwurx (PCSA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Lipocine (LPCN) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.99
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00